Breakdown | ||||
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
3.88B | 3.94B | 3.78B | 3.61B | 2.91B | Gross Profit |
1.50B | 1.59B | 1.31B | 1.31B | 1.05B | EBIT |
655.90M | 767.40M | 741.40M | 682.60M | 472.80M | EBITDA |
902.60M | 976.07M | 934.24M | 844.20M | 594.80M | Net Income Common Stockholders |
424.00M | 510.20M | 512.00M | 459.10M | 262.80M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
562.70M | 365.00M | 113.00M | 125.00M | 208.50M | Total Assets |
5.23B | 4.91B | 4.48B | 4.24B | 4.09B | Total Debt |
1.21B | 1.20B | 1.14B | 955.50M | 922.60M | Net Debt |
642.30M | 836.00M | 1.03B | 830.50M | 714.10M | Total Liabilities |
3.07B | 3.05B | 2.87B | 2.91B | 3.03B | Stockholders Equity |
2.16B | 1.86B | 1.61B | 1.33B | 1.06B |
Cash Flow | Free Cash Flow | |||
380.60M | 464.90M | 7.80M | 497.50M | 666.70M | Operating Cash Flow |
802.80M | 914.20M | 607.60M | 757.20M | 786.90M | Investing Cash Flow |
-446.70M | -470.50M | -660.10M | -348.20M | -120.40M | Financing Cash Flow |
-165.90M | -210.10M | -25.40M | -449.60M | -540.20M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $34.45B | 36.97 | 12.10% | 0.75% | -2.24% | 3.00% | |
77 Outperform | £60.87B | 19.05 | 15.72% | 1.64% | 2.11% | 3.37% | |
76 Outperform | $6.41B | 14.23 | 33.52% | 0.51% | 0.05% | 0.96% | |
75 Outperform | $32.70B | 31.19 | 11.88% | 0.58% | -0.54% | -48.61% | |
72 Outperform | $10.27B | 7.02 | 6.58% | 1.22% | -8.41% | 570.14% | |
72 Outperform | $11.23B | 26.89 | 21.05% | ― | -1.59% | -15.58% | |
51 Neutral | $2.03B | -1.27 | -21.09% | 3.98% | 2.91% | -30.50% |